Surgical biology for the clinician: vascular effects of immunosuppression - Wikidata - wikimedia - TriplyDB

Surgical biology for the clinician: vascular effects of immunosuppression

Surgical biology for the clinician: vascular effects of immunosuppression

http://www.wikidata.org/entity/Q33604754

about

The clinical characteristics of posterior reversible encephalopathy syndrome in patients with chronic renal failure.Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension.Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats.Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection Graft microvascular disease in solid organ transplantation.Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells.Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients.Immunosuppressive protocols with tacrolimus after cryopreserved aortal allotransplantation in rats

P2860

Q33847462-C8B2638F-2016-4B0B-9E21-48908460CCD3 Q34013918-486E9F7E-0C22-4188-ABC9-C5843817ABC4 Q34814081-6DFD21C3-D0D4-4C19-AF62-01D6F6436698 Q35117594-0F6D1675-300B-4911-B484-C6725141A449 Q35761558-102C49BC-952F-49D7-9772-ED838A061B4D Q38216381-92F684D8-0D8A-4226-BB94-7CE380571B5D Q39478990-80B3C6B8-0B84-4EB8-BCF8-FEFDE4D6B376 Q41888593-547F0C2A-DA7A-4569-9027-9EB3E22264B9 Q56927431-73B0B8B1-0318-405D-9DD3-711C6056C0AC

P2860

Surgical biology for the clinician: vascular effects of immunosuppression

http://www.wikidata.org/entity/Q33604754

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Surgical biology for the clinician: vascular effects of immunosuppression

@ast

Surgical biology for the clinician: vascular effects of immunosuppression

@en

type

label

Surgical biology for the clinician: vascular effects of immunosuppression

@ast

Surgical biology for the clinician: vascular effects of immunosuppression

@en

prefLabel

Surgical biology for the clinician: vascular effects of immunosuppression

@ast

Surgical biology for the clinician: vascular effects of immunosuppression

@en

P1433

Q33604754-D37EA24E-F310-4BD4-BCA6-98E8AC263FDE

P1476

Q33604754-B47BCA48-8CEB-4A8C-8A22-D9C60E15605F

P2093

Q33604754-01563224-A596-4A7C-95A6-3454A701EDF7

Q33604754-14B31077-DCD7-4334-87E3-E810E0B2B8C2

Q33604754-1CB79C81-CE53-4B3C-A2A1-0BC7C09CCE1D

Q33604754-239A4BE2-E4E9-451C-830A-ACDE16633C50

Q33604754-6ED19610-7DAD-4326-9967-0674C574C537

Q33604754-755149AA-A648-4770-8DFA-492F0E76DAB1

Q33604754-D194527C-D16D-492F-8B14-D7D07EB93152

P2860

Q33604754-00782BCD-AF0F-40DA-B698-275662923053

Q33604754-059AC24C-46F2-48F9-8895-C764FDFB6B13

Q33604754-0BD76DDC-F7F8-4641-9922-A3A273538D3F

Q33604754-0C3FBEF6-B0CB-4058-B551-8FD4C51C7A19

Q33604754-0CA429D6-4E3B-4E1A-B48B-3DF0FA0A8B5E

Q33604754-1BC9B500-0FF7-4812-BFE3-45B53CC15E4F

Q33604754-1CA89405-DBDE-422D-8BBB-B1D763593896

Q33604754-1EDB9EAD-73E3-48DF-906F-4BD2F1D95573

Q33604754-257FBE62-971C-4E38-AC43-5CFB85395049

Q33604754-2AE782CC-4027-4125-BFE2-58FF5A681FE5

P304

Q33604754-EE90634D-030E-464C-A217-18D6D3A16997

P31

Q33604754-06D93F85-F931-4DF1-B1A7-EF7FC7561112

P433

Q33604754-C4EE05C6-EE0D-487E-905E-EE86996F5508

P478

Q33604754-4998A49D-B31C-4485-8BCA-99227BE0728C

P577

Q33604754-A9D1FC08-5936-40EF-BAAE-FF06C1669802

P698

Q33604754-A7F2A2CF-9055-4E9E-BDC0-9C080CA6C048

P921

Q33604754-2AB25192-4BC7-4592-A42D-986716C78F22

P932

Q33604754-6946BCF9-9C07-4EDC-B9B2-FCA48EDF6F91

P1433

Canadian Journal of Surgery

P1476

Surgical biology for the clinician: vascular effects of immunosuppression

@en

P2093

Danny Ramzy

http://www.w3.org/2001/XMLSchema#string

Elissa Tepperman

http://www.w3.org/2001/XMLSchema#string

Heather Ross

http://www.w3.org/2001/XMLSchema#string

Jessica Prodger

http://www.w3.org/2001/XMLSchema#string

Mitesh Badiwala

http://www.w3.org/2001/XMLSchema#string

Rohit Sheshgiri

http://www.w3.org/2001/XMLSchema#string

Vivek Raoa

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial dysfunction in renal transplant recipients maintained on cyclosporine

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus

Benefit-risk assessment of sirolimus in renal transplantation.

Newer immunosuppressive drugs: a review.

Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.

A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results

Sirolimus: a comprehensive review.

The limitations of calcineurin and mTOR inhibitors: new directions for immunosuppressive strategies.

Regulation of the calmodulin-stimulated protein phosphatase, calcineurin.

P304

57-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20100415

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

2810018

http://www.w3.org/2001/XMLSchema#string